Global HIV Point-of-care Testing Market Size By Type (Testing Equipment, Testing Reagent), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global HIV Point-of-care Testing Market was valued at USD 1.1 billion in 2023 and is projected to reach USD 2.3 billion by 2031, growing at a CAGR of 9.5% during the forecast period of 2023–2031. The market is gaining traction due to the urgent global need for early HIV detection, rapid diagnostics, and improved access to testing, especially in low-resource settings. Point-of-care (POC) HIV testing plays a critical role in timely diagnosis and immediate linkage to care, making it a vital tool in the fight against the HIV/AIDS epidemic. The increasing adoption of rapid diagnostic technologies, public health initiatives, and rising awareness are fueling the market growth.

Drivers:

1. Rising Global Prevalence of HIV:

With over 38 million people living with HIV worldwide, the demand for early and decentralized testing is critical. POC testing helps in diagnosing individuals in remote and underserved regions, reducing transmission and improving health outcomes.

2. Technological Advancements in Rapid Diagnostics:

Innovations such as lateral flow immunoassays, molecular diagnostics, and smartphone-integrated test kits are enhancing the accuracy, speed, and user-friendliness of HIV POC tests, expanding their application scope.

3. Government and NGO-led Screening Initiatives:

Government healthcare programs and support from international health organizations such as WHO, UNAIDS, and PEPFAR have increased funding and infrastructure for rapid HIV testing, especially in Africa and Southeast Asia.

Restraints:

1. Limited Sensitivity in Early Detection:

Some rapid HIV POC tests may have reduced sensitivity in detecting early-stage infections, leading to false negatives and delayed treatment, which impacts reliability and confidence among users.

2. Inadequate Infrastructure in Rural Regions:

In regions with poor healthcare infrastructure, logistical issues such as supply chain gaps, lack of trained personnel, and irregular testing supplies hinder the widespread implementation of POC testing solutions.

Opportunity:

1. Expansion in Emerging Markets:

Asia-Pacific, Latin America, and Sub-Saharan Africa represent untapped potential for HIV POC testing, with growing public health investments and rising disease awareness.

2. Integration with Digital Health Platforms:

The integration of point-of-care diagnostics with mobile apps, cloud-based reporting systems, and telehealth services offers immense opportunities for real-time surveillance, patient monitoring, and data collection.

Market by System Type Insights:

The Lateral Flow Immunoassay-based Test Kits segment accounted for the largest market share in 2023. These kits are affordable, require minimal training, and deliver results within minutes, making them ideal for mass screening in both urban and rural settings. Meanwhile, molecular diagnostic devices are gaining momentum, particularly in developed regions, due to their high sensitivity and application in early infection detection.

Market by End-use Insights:

The Clinics & Community Healthcare Centers segment dominated the end-use category in 2023. These settings are the first line of care in many developing countries and are often supported by NGOs and public health organizations. Meanwhile, the home testing segment is projected to grow rapidly due to increased consumer demand for privacy and convenience.

Market by Regional Insights:

In 2023, Sub-Saharan Africa held the largest market share, driven by the region's high HIV prevalence and robust support from international donor programs. North America and Europe follow, supported by technological advancements and high testing rates. Asia-Pacific is projected to be the fastest-growing region due to expanding healthcare access and increased screening programs.

Competitive Scenario:

Key players in the global HIV Point-of-care Testing Market include Abbott Laboratories, bioLytical Laboratories, Chembio Diagnostics, OraSure Technologies, F. Hoffmann-La Roche AG, Siemens Healthineers, and Bio-Rad Laboratories. These companies focus on product innovation, regulatory approvals, partnerships with NGOs, and expansion into high-burden regions.

Recent developments include:

In 2024, OraSure Technologies expanded its OraQuick HIV Self-Test distribution across several African nations in partnership with Unitaid.

In 2023, Abbott launched an enhanced version of its Determine™ HIV-1/2 Ag/Ab Combo test with improved early detection features.

In 2022, Chembio Diagnostics received CE marking for its dual HIV/Syphilis test, improving multiplex testing capabilities for field workers.

Scope of Work – Global HIV Point-of-care Testing Market

Report Metric Details

Market Size (2023) USD 1.1 billion

Projected Market Size (2031) USD 2.3 billion

CAGR (2023–2031) 9.5%

Market Segments By System Type (Lateral Flow, Molecular), End-use (Clinics, Home Use)

Growth Drivers Rising HIV prevalence, rapid diagnostics, public health screening programs

Opportunities Digital integration, emerging markets, self-testing expansion

Key Market Developments:

2024: OraSure expanded its HIV self-testing kit distribution under a WHO prequalification initiative.

2023: Roche Diagnostics launched a smartphone-compatible HIV POC molecular test for remote clinics.

2022: bioLytical introduced a dual HIV/HCV test for use in low-resource field settings.

FAQs:

1. What is the current market size of the Global HIV Point-of-care Testing Market?

The market was valued at USD 1.1 billion in 2023.

2. What is the major growth driver of the Global HIV Point-of-care Testing Market?

The major growth driver is the rising global prevalence of HIV and the urgent need for early, decentralized testing.

3. Which is the largest region during the forecast period in the Global HIV Point-of-care Testing Market?

Sub-Saharan Africa is the largest region, driven by high prevalence and strong NGO/government support.

4. Which segment accounted for the largest market share in the Global HIV Point-of-care Testing Market?

The Lateral Flow Immunoassay-based Test Kits segment held the largest market share in 2023.

5. Who are the key market players in the Global HIV Point-of-care Testing Market?

Key players include Abbott Laboratories, OraSure Technologies, Chembio Diagnostics, bioLytical Laboratories, Roche, and Siemens Healthineers.

Let me know if you'd like this as a formatted PDF or DOCX file!